Esperion Therapeutics, Inc.
News
Headlands Technologies LLC Makes New $613,000 Investment in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Ticker Report Headlands Technologies LLC bought a new stake in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) in the second quarter, according to its most recent filing with the Securities and...\n more…
Esperion Therapeutics (NASDAQ:ESPR) Downgraded by StockNews.com to "Hold"
Ticker Report StockNews.com lowered shares of Esperion Therapeutics (NASDAQ:ESPR - Free Report) from a buy rating to a hold rating in a report released on Wednesday. Several other equities research analysts also...\n more…
Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?
Zacks Investment Research It has been about a month since the last earnings report for Esperion Therapeutics (ESPR). Shares have lost about 3.9% in that time frame, underperforming the S&P 500.Will the recent negative trend...\n more…
20,000 Shares in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Bought by Sivia Capital Partners LLC
Zolmax Sivia Capital Partners LLC bought a new position in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) during the second quarter, according to its most recent filing with the...\n more…
Sivia Capital Partners LLC Invests $44,000 in Esperion Therapeutics, Inc. (NASDAQ:ESPR)
Ticker Report Sivia Capital Partners LLC purchased a new position in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) during the second quarter, according to the company in its most recent 13F...\n more…
Esperion to Participate in Upcoming 2024 Cantor Global Healthcare Conference
Globe Newswire ANN ARBOR, Mich., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted 2024 Cantor Global Healthcare Conference on...\n more…